-
1دورية أكاديمية
المؤلفون: Sheng-Fu Chen, Yao-Chi Chuang, Chung-Cheng Wang, Chun-Hou Liao, Hann-Chorng Kuo
المصدر: Journal of the Formosan Medical Association, Vol 121, Iss 10, Pp 2101-2108 (2022)
مصطلحات موضوعية: Central nervous system, Cognitive impairment, Overactive bladder, Mirabegron, Antimuscarinics, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S0929664622001474Test; https://doaj.org/toc/0929-6646Test
-
2دورية أكاديمية
المؤلفون: Rachel A. High, Jill M. Danford, Zhaoyue Shi, Christof Karmonik, Thomas J. Kuehl, Erin T. Bird, Rose Khavari
المصدر: Contemporary Clinical Trials Communications, Vol 19, Iss , Pp 100621- (2020)
مصطلحات موضوعية: Urinary incontinence, Overactive bladder syndrome, Solifenacin, Mirabegron, Cognitive dysfunction, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2451865420301058Test; https://doaj.org/toc/2451-8654Test
-
3دورية أكاديمية
المؤلفون: Becker, M., Serr, I., Salb, V.K., Ott, V., Mengel, L., Blüher, M., Weigmann, B., Hauner, H., Tschöp, M.H., Daniel, C.
المصدر: Mol. Metab. 28, 73-82 (2019)
مصطلحات موضوعية: Regulatory T Cell, Human Adipose Tissue, Beta3-adrenergic Stimulation, Mirabegron, Immunometabolism, Humanized Mice
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000487684000007; info:eu-repo/semantics/altIdentifier/isbn/2212-8778; info:eu-repo/semantics/altIdentifier/pissn/2212-8778; info:eu-repo/seman; https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=56776Test; urn:isbn:2212-8778; urn:issn:2212-8778
الإتاحة: https://doi.org/10.1016/j.molmet.2019.08.002Test
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=56776Test -
4
المصدر: European Urology. 79(4):492-504
مصطلحات موضوعية: Overactive bladder, URINARY-TRACT SYMPTOMS, Men, BENIGN PROSTATIC HYPERPLASIA, EFFICACY, DETRUSOR OVERACTIVITY, Antimuscarinics, DOUBLE-BLIND, STORAGE SYMPTOMS, QUALITY-OF-LIFE, SAFETY, MIRABEGRON, Lower urinary tract symptoms, TRANSURETHRAL RESECTION
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od________83::a33cc282378ab31661f771273855a7f3Test
https://doi.org/10.1016/j.eururo.2020.12.032Test -
5
المصدر: European Urology Focus. 5(6):1112-1119
مصطلحات موضوعية: Pharmacology, Incontinence, PERSISTENCE, Urgency, ANTIMUSCARINIC AGENTS, ANTICHOLINERGIC PROPERTIES, Medication, COGNITIVE FUNCTION, EFFICACY, THERAPY, DOUBLE-BLIND, ADHERENCE, Overactive bladder syndrome, MIRABEGRON, Drug, SOLIFENACIN
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od________83::0ae9929c710d57fca79423e9beb66e64Test
https://cris.maastrichtuniversity.nl/en/publications/d9c18362-ae95-486a-84bb-913bff1c73e3Test -
6
المؤلفون: M.G. Çulha, A. Otunctemur, E. Abay, O. Akan, F. Altunrende
المصدر: European Urology Open Science, Vol 19, Iss, Pp e288-(2020)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, Disease, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Myasthenia gravis, Overactive bladder, medicine, In patient, Mirabegron, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d08bc26e2bd13723db88e7b37235ccTest
http://www.sciencedirect.com/science/article/pii/S2666168320327476Test -
7
المؤلفون: Kyu-Sung Lee, Hidehiro Kakizaki, Satoshi Uno, Osamu Yamaguchi, Budiwan Sumarsono, Daisuke Katou, Osamu Yamamoto
المصدر: European Urology Open Science, Vol 19, Iss, Pp e633-(2020)
Advances in Therapyمصطلحات موضوعية: Tamsulosin, Male, 030213 general clinical medicine, medicine.medical_specialty, Post hoc, Add-on, Urology, Muscarinic Antagonists, Placebo, lcsh:RC870-923, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Quality of life, Internal medicine, Post-hoc analysis, Humans, Medicine, Single-Blind Method, Pharmacology (medical), Original Research, Aged, Mirabegron, Urinary Bladder, Overactive, business.industry, Overactive bladder, Responder, General Medicine, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Rheumatology, Add on therapy, Thiazoles, Treatment Outcome, 030220 oncology & carcinogenesis, Quality of Life, Urological Agents, Acetanilides, Drug Therapy, Combination, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8d4965277f1ad5293257ae01ad2b9dTest
http://www.sciencedirect.com/science/article/pii/S2666168320329943Test -
8
المؤلفون: Erin T. Bird, Thomas J. Kuehl, Jill M. Danford, Zhaoyue Shi, Christof Karmonik, Rachel High, Rose Khavari
المصدر: Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100621-(2020)مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Population, Urinary incontinence, Placebo, Article, 03 medical and health sciences, 0302 clinical medicine, Cognitive dysfunction, Internal medicine, Anticholinergic, Medicine, Dementia, 030212 general & internal medicine, education, Pharmacology, Mirabegron, lcsh:R5-920, education.field_of_study, Solifenacin, business.industry, General Medicine, medicine.disease, Institutional review board, Overactive bladder, Overactive bladder syndrome, lcsh:Medicine (General), business, 030217 neurology & neurosurgery, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fefb7f3985aba784e630818058a2c0Test
http://europepmc.org/articles/PMC7381509Test -
9
المؤلفون: T. Komi, Takehiro Sejima, K. Ono, Atsushi Takenaka, H. Matsuoka, N. Sakaridani, Masashi Honda, Y. Kimura, T. Isoyama, C. Takahashi
المصدر: European Urology Open Science, Vol 19, Iss, Pp e629-(2020)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, Hyperplasia, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Tadalafil, Combined treatment, medicine, In patient, Mirabegron, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd8533d086b2ae96a5d4cf114685889Test
http://www.sciencedirect.com/science/article/pii/S2666168320329918Test -
10
المؤلفون: Lisa F. Wolfe, Anna P. Lam, John M. Coleman, Elizabeth S. Malsin
المصدر: Respiratory Medicine Case Reports, Vol 26, Iss, Pp 304-306 (2019)
Respiratory Medicine Case Reportsمصطلحات موضوعية: Pulmonary and Respiratory Medicine, Neuromuscular disease, Case Report, Neuromuscular lung disease, Aspiration pneumonia, Pulmonary function testing, 03 medical and health sciences, 0302 clinical medicine, medicine, Restrictive lung disease, Adverse effect, lcsh:RC705-779, Adverse medication effect, β3 receptor agonist therapy, business.industry, lcsh:Diseases of the respiratory system, medicine.disease, 3. Good health, Discontinuation, 030228 respiratory system, Overactive bladder, 030220 oncology & carcinogenesis, Anesthesia, business, Mirabegron, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69fa441bb7fca906c5e6778bafbd6886Test
http://www.sciencedirect.com/science/article/pii/S2213007119300036Test